跳转到主要内容
搜索

Radnor, PA – 2025 年 6 月 20 日 – Certara, Inc. (纳斯达克股票代码:CERT), a global leader in model-informed drug development, today announced the release of Integral™ version 25.4.1, the latest update to its secure cloud-based platform for document management and e-signature workflows. This release introduces significant upgrades to the REST API, enabling customers to build integrated, efficient, and scalable pharmacokinetic (PK) data workflows.

合规性
Visualize
Analyze
Exploratory
Capture
建立联系

Designed to meet the evolving needs of regulatory, clinical, and IT teams, Integral 25.4.1 helps life sciences organizations streamline operations, automate routine tasks, and more easily connect Integral with other systems and processes including Phoenix, Certara’s pharmacokinetic/pharmacodynamic analysis and modeling platform. “This release gives our customers more power and flexibility to automate their work and integrate Integral into their broader digital ecosystem,” said Martin Snyder, President, Certara Data Sciences. “It reflects our continued investment in making the platform smarter, faster, and easier to manage.”

Key Highlights of Integral 25.4.1:

  • REST API Enhancements: A broader range of API endpoints for flexibility in managing folders and files from outside the application, accelerating integration with other data sources.
  • Single Sign-On and Centralized Administration: Unified access management through Certara Admin across all Certara products.
  • Streamlined eSignature Workflow: Faster, plugin-free signing experience that aligns with Certara’s modern authentication framework.
  • Expanded Logging and Audit Trails: Increased transparency into user sessions and administrative actions, supporting 21 CFR Part 11 compliance and security goals.

These updates are part of Certara’s broader vision to provide a seamless and scalable platform that evolves alongside customer needs in drug development and regulatory environments. The Integral release coincides with the release of Phoenix 8.6.

To learn more about Integral and the latest enhancements, visit https://www.certara.com/integral-data-repository/

关于Certara

Certara 致力于通过生物模拟软件、技术和服务加速药物研发,改变传统的药物研发方式。其客户包括超 2,400 家生物制药公司、学术机构和来自 70 个国家的监管机构。Learn more at certara.com.

Certara 联系人:

Sheila Rocchio
[email protected]

媒体联系人:

Alyssa Horowitz
[email protected]

Increase the efficiency of your PK analysis from repository to report

In this webinar, Jocelyn Webb, Associate Director of Global Pharmacokinetics at Charles River Laboratories, shared how her team built a workflow designed for efficiency and consistency, highlighting the roles of Integral and other features of the Phoenix Platform.

点击观看网络研讨会

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software